Scott P. Bruder, MD, PhD, is the Senior Vice President and Chief Science and Technology Officer of BD, where he is an Executive Officer of the Company, and a member of the Office of the CEO. He is responsible for providing technology, strategy and development leadership to the company as it focuses on innovation and impact in medical devices, diagnostics and biosciences. He leads the Research & Development function across the Corporation, and until 2011, also led corporate strategic planning and business development.
Dr. Bruder joined BD in 2007, and has focused his efforts on identifying and developing promising technologies to address unmet health care needs and emerging life science research trends. He leads the Company’s effort to continuously improve the product development system, manage a diverse portfolio of R&D investments, globalize the R&D function and footprint, and develop outstanding leaders around the world.
Prior to joining BD, Dr. Bruder served in a variety of senior executive and scientific roles. He spent eight years at Johnson & Johnson, where he developed a corporate-wide strategic plan and led the creation of Johnson & Johnson Regenerative Therapeutics, LLC, which was responsible for innovative biotechnology products to treat musculoskeletal, gynecologic, neurologic and other conditions. Before serving as a Worldwide Vice President at J&J, he held various other Vice President roles in basic, applied and clinical research at J&J and Anika Therapeutics. Earlier in his career, Dr. Bruder led technology transfer and orthopaedic product development for Osiris Therapeutics, specializing in biomaterial and stem cell therapies.
Dr. Bruder is an accomplished researcher and innovator, with more than 20 issued and pending U.S. and international patents. He has published nearly 150 original articles, book chapters and abstracts in peer-reviewed journals, and he is a distinguished lecturer at societies, universities and industry events around the world. His pioneering work on the characterization and clinical application of human mesenchymal stem cells and recombinant growth factors earned him both academic and industry acclaim, as well as numerous scientific honors.
Dr. Bruder holds an Adjunct Faculty position at Case Western Reserve University, is a Trustee of the Liberty Science Center in New Jersey, and serves on the Industrial Advisory Boards at the New York Stem Cell Foundation, Brown University, and the Case School of Engineering. Prior to embarking on his industrial career, Dr. Bruder held several academic positions, including an Arthritis Foundation Fellowship, and a Clinical Instructorship at the University of Pennsylvania.
Dr. Bruder is a magna cum laude graduate from Brown University, as well as Case Western Reserve University School of Medicine, where he also earned a PhD in stem cell biology. He received additional postgraduate clinical training at Albert Einstein Medical Center and the University of Pennsylvania.